APA (7th ed.) Citation

SC, W., FL, C., WL, L., PH, W., & CP, H. (2011). Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2: Comment on: 'A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol. 2010; 65(6): 1009-1021'. Cancer Chemotherapy & Pharmacology, 67(1), 243. https://doi.org/10.1007/s00280-010-1490-y

Chicago Style (17th ed.) Citation

SC, Wang, Chen FL, Lin WL, Wang PH, and Han CP. "Cytokeratin 8/18 Monoclonal Antibody Was Dissimilar to Anti-cytokeratin CAM 5.2: Comment on: 'A Randomized Phase III Study of Adjuvant Platinum/docetaxel Chemotherapy with or Without Radiation Therapy in Patients with Gastric Cancer. Cancer Chemother Pharmacol. 2010; 65(6): 1009-1021'." Cancer Chemotherapy & Pharmacology 67, no. 1 (2011): 243. https://doi.org/10.1007/s00280-010-1490-y.

MLA (9th ed.) Citation

SC, Wang, et al. "Cytokeratin 8/18 Monoclonal Antibody Was Dissimilar to Anti-cytokeratin CAM 5.2: Comment on: 'A Randomized Phase III Study of Adjuvant Platinum/docetaxel Chemotherapy with or Without Radiation Therapy in Patients with Gastric Cancer. Cancer Chemother Pharmacol. 2010; 65(6): 1009-1021'." Cancer Chemotherapy & Pharmacology, vol. 67, no. 1, 2011, p. 243, https://doi.org/10.1007/s00280-010-1490-y.